Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.
about
Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO databaseCiprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studiesQuinolone resistance in absence of selective pressure: the experience of a very remote community in the Amazon forestIntegrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesSpontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.Ethnomedicinal and phytochemical review of Pakistani medicinal plants used as antibacterial agents against Escherichia coli.Population-based epidemiologic analysis of acute pyelonephritis.Probiotics. Some evidence of their effectivenessCefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women.Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines.Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.Antimicrobial-resistant invasive Escherichia coli, SpainMutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: an analysis of national representative claims databaseCefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.Association between antimicrobial consumption and resistance in Escherichia coli.Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.Resistance to β-lactams in bacteria isolated from different types of Portuguese cheesePrevalence and risk factor analysis of resistant Escherichia coli urinary tract infections in the emergency department.Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications.Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of meerut city, India.A European study on the relationship between antimicrobial use and antimicrobial resistance.Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study.Antimicrobial resistance of Escherichia coli strains causing community-acquired urinary tract infections among insured and uninsured populations in a large urban center.Does intravenous cefuroxime improve the efficacy of ciprofloxacin for preventing infectious complications after transrectal prostate biopsy? A prospective comparative study.Community-acquired febrile urinary tract infection in diabetics could deserve a different management: a case-control study.Evaluation of quinolone resistance in gram negative bacilli isolated from community- and hospital-acquired infections.Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval.Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.Antimicrobial resistance impacts clinical outcome of granulomatous colitis in boxer dogs.Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.Antibiotic resistance of urinary pathogens in female general practice patients.
P2860
Q23760719-C7B9BD3B-AF29-4EC2-B1A7-491BEF8A5322Q26775453-3C17F794-906D-4D6C-B07D-75BC11DCE5A5Q28482785-248F3324-FF65-429E-BD86-3D56D0D8C997Q30992335-FF17CCCE-C7C7-445B-A689-3E67E63F5D70Q33555328-3AA07E6E-85E4-4E96-B625-8980E3D70440Q33983331-A2FF7716-B28F-4F69-929A-34BDD29AC66BQ34014804-297CD8B3-EB8A-40FF-B638-A2645F55D4EBQ34110686-F2E682D0-ADD3-442F-9B99-A3CF2F387B67Q34123760-5CB5EC68-54EB-4660-96A3-0A142657E7FBQ34537795-FB83BE97-7086-43C1-86D9-21197E234C27Q34643113-597D18D2-4F7A-485B-9813-8335B3C15FD2Q34682352-A2205CB7-FB1B-46BD-945F-DA9946586EFCQ34734798-5997D8E6-BF12-489A-A2F4-2E98801DB5BAQ35031841-E122ADC2-C085-4B57-8381-86D77F7C6393Q35648288-A016721B-D5DE-4D91-9388-272D57CEBF58Q35872947-20EBB466-4862-493D-B46B-76BCCE0424A3Q36048167-5DAEAEE8-E6D4-486D-B688-9C91D0EBCB8EQ36153920-9A8FAEBB-41F4-4674-9CFE-C747488B1F97Q37079106-985A496D-F6A8-41E7-880F-5DB75B67A896Q37115726-8A26C394-1685-4C3D-93AA-662588BA2AF6Q37115781-D782D292-C8BE-45A3-A304-825AA350EBF2Q37188234-66397ECE-93A5-4AC8-B5C9-B3132A783DADQ37233393-6AECCE45-EE89-45BE-A2DB-D98FBDD0CC6DQ37264321-9A203ECB-EBDF-4AFA-ACCF-597410E1FBA5Q37291366-C00143C9-897C-492C-BE6B-DEC814EBCA3CQ37316260-570C1DB0-0C70-4FB8-AED2-6271EF60E417Q37320119-A89244CC-2214-450E-A6C3-55C8FA9D1560Q37392904-D50CAF57-E727-4E8F-A4E3-FA4638CE0FB1Q37405774-4D9FC96A-4289-41EE-9BE6-52AE46959B8BQ39776425-DAB51273-F87F-460C-8A7D-9D21D2677E97Q40266354-EB9931C0-3739-4A6D-B3C6-3CB9A0470179Q40551854-D59B0077-A65F-492B-B9C2-B93F4F1DC3ADQ41808240-6A43C74D-0F91-49AF-BCA9-3D030A83359DQ42000458-0908E6AC-AC9D-4EF5-BBB0-458B3AC7B9AFQ42637997-96B11C59-68AD-41F2-8CA6-8988E7567D1FQ42947800-248A8B9C-2073-4264-8B52-5469CC2320EAQ42978682-3D6378CE-B7EB-4660-BC2E-BDD72ACDA502Q43056997-AF82D217-2BDB-42BE-B2F2-20F09606B8C7Q43110171-12AC533F-99F0-4D51-B7C7-D8111FB5D957Q43751271-F5591731-76F3-4DD8-BB6B-BCD7A59A2E67
P2860
Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Increasing resistance to fluor ...... infections in the netherlands.
@en
type
label
Increasing resistance to fluor ...... infections in the netherlands.
@en
prefLabel
Increasing resistance to fluor ...... infections in the netherlands.
@en
P2093
P356
P1476
Increasing resistance to fluor ...... infections in the netherlands.
@en
P2093
Buiting AG
Goettsch W
Hendrix MG
Nagelkerke N
de Neeling AJ
van Griethuysen AJ
van Pelt W
P304
P356
10.1093/JAC/46.2.223
P407
P577
2000-08-01T00:00:00Z